As drug prices escalate, politicians in Washington and states have sought to address the problem in limited ways, focusing mostly on insulin, which more than 7 million Americans rely on to manage diabetes and whose price more than doubled from 2012-17.
Why would pharma companies be OK with a Rose Garden event celebrating a $150 billion deal but then balk at a Rose Garden event that included the $100 cards?
The White House and the pharmaceutical industry were nearing a major deal to lower drug prices. Then the administration demanded that $100 cash cards be sent to millions of seniors before the election — and the industry balked.
American cancer prices start high and keeps going higher.
This diagram contains an aggregation of publicly available information (from validated sources) on the development of treatments and vaccines for COVID-19.
How drugs are valued in France.